(Q80149209)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

At once harmful and beneficial: the dual properties of NF-kappaB (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Sawsan Youssef

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lawrence Steinman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

901-902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

Design of effective immunotherapy for human autoimmunity

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Janus faces of NF-kappa B: neurodestruction versus neuroprotection

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Missing pieces in the NF-kappaB puzzle

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Regulation of immune responses by NF-kappa B/Rel transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Regulation of naive T cell function by the NF-kappaB2 pathway

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Multiple sclerosis: trapped in deadly glue

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Nuclear factor kappa B: important transcription factor and therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Proteasome inhibitor drugs on the rise

1 reference

https://api.crossref.org/works/10.1038%2FNI0906-901

7 January 2021

Identifiers

DOI

10.1038/NI0906-901

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16924250%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference